Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about MilestonePharmaceuticalsInc-2020-10-22
$51.7 Million
Image
Milestone Pharmaceuticals Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about OcularTherapeutixInc-2020-10-13
$80.5 Million
Image
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about CardiffOncologyInc-2020-09-29
$100.9 Million
Image
Cardiff Oncology Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ChiasmaInc-2020-07-01
$80.5 Million
Image
Chiasma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about AltimmuneInc-2020-07-13
$115.0 Million
Image
Altimmune, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about HarpoonTherapeuticsInc-2021-01-06
$115.0 Million
Image
Harpoon Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about NeoleukinTherapeutics-2020-07-01
$76.3 Million
Image
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about OtonomyInc-2020-07-09
$69.1 Million
Image
Otonomy, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about LeapTherapeutics-2020-06-17
$40.0 Million
Image
Leap Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ChemoCentryxInc-2020-06-10
$346.8 Million
Image
ChemoCentryx, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 25
Next page
››
Subscribe to Active Bookrunner